TP53 and hepatocellular carcinoma: In a mouse model of hepatocellular carcinoma with p53 mutations and RB loss, forced expression of RB sensitized tumor cells to palbociclib and a similar phenotype was observed when a non-phosphorylatable form of RB was expressed in the tumors [85].